Recall of Leica Bond Polymer Refine Red Detection System

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by Leica Biosystems Newcastle Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    15104
  • Event Initiated Date
    2013-08-06
  • Event Country
  • Event Source
    NZMMDSA
  • Event Source URL
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Leica BioSystems Melbourne Pty Ltd, 495 Blackburn Road, Mt Waverley, VIC 3149, AUSTRALIA
  • Reason
    Leica biosystems newcastle ltd has identified several batches of bond detection systems where the polymer ap component contains a contaminant of fungus.
  • Action
    Product to be destroyed

Device

Manufacturer